Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Showing 20 of 0 results

Not applicableEnded earlyNCT01798576
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 282
Testing effectiveness (Phase 2)Study completedNCT02601573
What this trial is testing

Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Cirrhotic Subjects With Chronic Hepatitis C Virus (HCV) Genotype 3 (GT3) Infection (MK-5172-083)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 101
Post-approval studies (Phase 4)Ended earlyNCT00493805
What this trial is testing

Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)

Who this might be right for
Hepatitis C, ChronicInsulin Resistance
Merck Sharp & Dohme LLC 59
Post-approval studies (Phase 4)Study completedNCT00087646
What this trial is testing

REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 948
Not applicableStudy completedNCT03612973
What this trial is testing

Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy

Who this might be right for
Chronic Hepatitis c
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT00680342
What this trial is testing

Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment

Who this might be right for
Chronic Hepatitis C
National Center for Complementary and Integrative Health (NCCIH) 154
Early research (Phase 1)Study completedNCT01144936
What this trial is testing

Study of VX-985 in Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 21
Early research (Phase 1)Ended earlyNCT03253471
What this trial is testing

A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Alios Biopharma Inc. 24
Testing effectiveness (Phase 2)Study completedNCT02356562
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 29
Testing effectiveness (Phase 2)Study completedNCT00110799
What this trial is testing

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

Who this might be right for
Hepatitis C, ChronicHepatitis CThrombocytopenia
GlaxoSmithKline 75
Post-approval studies (Phase 4)Study completedNCT00152581
What this trial is testing

Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication

Who this might be right for
Chronic Hepatitis C, HCV Genotype 1
University College London Hospitals 40
Not applicableStudy completedNCT01667081
What this trial is testing

Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 2,438
Early research (Phase 1)Ended earlyNCT01567540
What this trial is testing

A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Institut National de la Santé Et de la Recherche Médicale, France 3
Post-approval studies (Phase 4)Study completedNCT00800748
What this trial is testing

Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 372
Not applicableUnknownNCT05813691
What this trial is testing

Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative.

Who this might be right for
Hepatitis C, ChronicHepatitis CHepatitis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 4,000
Testing effectiveness (Phase 2)Study completedNCT00684268
What this trial is testing

Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders

Who this might be right for
Hepatitis C
Medical University of Vienna 70
Testing effectiveness (Phase 2)Study completedNCT00221650
What this trial is testing

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected Patients

Who this might be right for
HIV InfectionsHepatitis C, ChronicTreatment Failure
University Hospital, Bordeaux 17
Early research (Phase 1)Study completedNCT01919125
What this trial is testing

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 36
Not applicableStudy completedNCT02636608
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary

Who this might be right for
Chronic Hepatitis C
AbbVie 244
Early research (Phase 1)Ended earlyNCT00954993
What this trial is testing

Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 3
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation